Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Papillomavirus Vaccines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT07668271
What this trial is testing

Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli)

Who this might be right for
Infection by Human Papilloma Virus
Xiamen Innovax Biotech Co., Ltd 720
Not applicableStudy completedNCT02236273
What this trial is testing

Interactive, Health Literacy Promoting Text Messages and HPV Vaccine Completion In Minority Adolescents

Who this might be right for
Human Papillomavirus
Columbia University 956
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Not applicableStudy completedNCT00573651
What this trial is testing

Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis

Who this might be right for
Arthritis
University Hospitals Cleveland Medical Center 43
Large-scale testing (Phase 3)Study completedNCT03431246
What this trial is testing

Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9

Who this might be right for
Human Papillomavirus Vaccines
Laval University 32
Not applicableStudy completedNCT00806676
What this trial is testing

Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Johns Hopkins University 67
Testing effectiveness (Phase 2)Study completedNCT00365378
What this trial is testing

Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005)

Who this might be right for
HPV 16 Infection
Merck Sharp & Dohme LLC 2,409
Testing effectiveness (Phase 2)Study completedNCT03946358
What this trial is testing

Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckAnal Canal CancerCervical Cancer
Centre Hospitalier Universitaire de Besancon 47
Large-scale testing (Phase 3)Study completedNCT00380367
What this trial is testing

Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 110
Large-scale testing (Phase 3)Active Not RecruitingNCT02834637
What this trial is testing

A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls

Who this might be right for
Human Papilloma Virus
London School of Hygiene and Tropical Medicine 930
Testing effectiveness (Phase 2)Study completedNCT04260126
What this trial is testing

Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC

Who this might be right for
Metastatic Head and Neck CancerRecurrent Head and Neck CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more
PDS Biotechnology Corp. 95
Large-scale testing (Phase 3)Study completedNCT00988884
What this trial is testing

V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)

Who this might be right for
Human Papillomavirus Infection
Merck Sharp & Dohme LLC 1,241
Not applicableTemporarily pausedNCT06002282
What this trial is testing

HPV Vaccine Confident Families

Who this might be right for
Human Papillomavirus Vaccines
Rutgers, The State University of New Jersey 70
Large-scale testing (Phase 3)Study completedNCT00426361
What this trial is testing

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 751
Not applicableActive Not RecruitingNCT05884697
What this trial is testing

Let's K-Talk - HPV Study for Ethnic Koreans

Who this might be right for
Human Papillomavirus VirusesPapillomavirus Vaccines
University of Cincinnati 120
Not applicableStudy completedNCT01769560
What this trial is testing

MeFirst: A Tailored Intervention to HPV Vaccine Decision Making

Who this might be right for
Human Papillomavirus-Related Carcinoma
University of Michigan 661
Large-scale testing (Phase 3)Study completedNCT00316706
What this trial is testing

Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine

Who this might be right for
Cervical Intraepithelial NeoplasiaPapillomavirus Infection
GlaxoSmithKline 1,245
Early research (Phase 1)Study completedNCT03813940
What this trial is testing

Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Condylomata AcuminataCervical Cancer
Xiamen University 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05108870
What this trial is testing

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

Who this might be right for
Human Papilloma VirusHPVHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more
University of Chicago 35
Large-scale testing (Phase 3)Study completedNCT01277042
What this trial is testing

Study to Assess Immune Responses and Safety of the GSK-580299 Vaccine in Healthy Women (26 to 45 Years)

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,212
Next Page